[Federal Register Volume 78, Number 198 (Friday, October 11, 2013)]
[Notices]
[Pages 62007-62008]
[FR Doc No: 2013-24438]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 349-182]

Alabama Power Company; Notice of Application Accepted for Filing,
Soliciting Comments, Motions To Intervene, and Protests

    Take notice that the following hydroelectric application has been
filed with the Commission and is available for public inspection:

    a. Application Type: Non-project use of project lands and waters.
    b. Project No.: 349-182.
    c. Date Filed: August 16, 2013, and supplemented on September 12,
2013.
    d. Applicant: Alabama Power Company.
    e. Name of Project: Martin Dam Hydroelectric Project.
    f. Location: Tallapoosa River in Tallapoosa County, Alabama.
    g. Filed Pursuant to: Federal Power Act, 16 U.S.C. 791a-825r.
    h. Applicant Contact: Amy Stewart, Shoreline Compliance, Alabama
Power Company, 600 18th Street North, Birmingham, AL 35203-8180, (205)
257-1000.
    i. FERC Contact: Mark Carter,<PHONE_NUMBER><EMAIL_ADDRESS>    j. Deadline for filing comments, motions to intervene, and
protests: November 4, 2013.
    All documents may be filed electronically via the Internet. See 18
CFR 385.2001(a)(1)(iii) and the instructions on the Commission's Web
site at http://www.ferc.gov/docs-filing/efiling.asp. Commenters can
submit brief comments up to 6,000 characters, without prior
registration, using the eComment system at http://www.ferc.gov/docs-filing/ecomment.asp. You must include your name and contact information
at the end of your comments. For assistance, please contact FERC Online
Support at<EMAIL_ADDRESS>or toll free at 1-866-208-3676,
or for TTY,<PHONE_NUMBER>. Although the Commission strongly encourages
electronic filing, documents may be paper-filed. To paper-file, mail an
original and seven copies to: Secretary, Federal Energy Regulatory
Commission, 888 First Street NE., Washington, DC 20426. Please include
the project number (P-349-182) on any comments or motions filed.
    The Commission's Rules of Practice and Procedure require all
intervenors filing documents with the Commission to serve a copy of
that document on each person whose name appears on the official service
list for the project. Further, if an intervenor files comments or
documents with the Commission relating to the merits of an issue that
may affect the responsibilities of a particular resource agency, they
must also serve a copy of the document on that resource agency.
    k. Description of Application: The licensee requests Commission
approval to authorize construction of marina facilities within the
project boundary associated with the Dixie Sailing Club. The marina's
facilities to be located inside the project boundary would include: (1)
2 boat ramps, one for year-round use and one for summer use only; (2) 7
floating docks that would accommodate 39 watercraft during the summer
(normal pool) and 22 watercraft during the winter (low pool); (3)
mooring buoy space for 12 watercraft in a cove of the lake; and (4) 300
linear feet of riprap for shoreline erosion control. In general, the
type of watercraft to be accommodated at the marina would be sailboats.
The marina's facilities would be associated with the Dixie Sailing
Club's clubhouse, parking area, dry boat storage, and other facilities
that would be constructed in the future outside the project boundary.
    l. Locations of the Application: A copy of the application is
available for inspection and reproduction at the Commission's Public
Reference Room, located at 888 First Street NE., Room 2A, Washington,
DC 20426, or by calling<PHONE_NUMBER>. This filing may also be viewed
on the Commission's Web site at http://www.ferc.gov using the
``eLibrary'' link. Enter the docket number excluding the last three
digits in the docket number field (P-349) to access the document. You
may also register online at http://www.ferc.gov/docs-filing/esubscription.asp to be notified via email of new filings and issuances
related to this or other pending projects. A copy is also available for
inspection and reproduction at the address in item (h) above.
    m. Individuals desiring to be included on the Commission's mailing
list should so indicate by writing to the Secretary of the Commission.
    n. Comments, Protests, or Motions to Intervene: Anyone may submit
comments, a protest, or a motion to intervene in accordance with the
requirements of Rules of Practice and Procedure, 18 CFR 385.210, .211,
and .214, respectively. In determining the appropriate action to take,
the Commission will consider all protests or other comments filed, but
only those who file a motion to intervene in accordance with the
Commission's Rules may become a party to the proceeding. Any comments,
protests, or motions to intervene must be received on or before the
specified comment date for the particular application.
    o. Filing and Service of Documents: Any filing must (1) bear in all
capital letters the title ``COMMENTS'', ``PROTEST'', or ``MOTION TO
INTERVENE'' as applicable; (2) set forth in the heading the name of the
applicant and the project number of the application to which the filing
responds; (3) furnish the name, address, and telephone number of the
person commenting, protesting or intervening; and (4) otherwise comply
with the requirements of 18 CFR 385.2001 through 385.2005. All
comments, motions to intervene, or protests must set forth their
evidentiary basis. Any filing made by an intervenor must be accompanied
by a proof of service on all persons listed in the service list
prepared by the Commission in this proceeding, in accordance with 18
CFR 385.2010.

    Dated: October 4, 2013.
Kimberly D. Bose,
Secretary.
[FR Doc. 2013-24438 Filed 10-10-13; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 195 (Wednesday, October 8, 2014)]
[Notices]
[Pages 60856-60857]
[FR Doc No: 2014-24001]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No: FDA-2014-N-0001]

Science Board to the Food and Drug Administration Advisory
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
    Name of Committee: Science Board to the Food and Drug
Administration (Science Board).
    General Function of the Committee: The Science Board provides
advice primarily to the Commissioner of Food and Drugs and other
appropriate officials on specific complex scientific and technical
issues important to the FDA and its mission, including emerging issues
within the scientific community. Additionally, the Science Board
provides advice to the Agency on keeping pace with technical and
scientific developments including in regulatory science, input into the
Agency's research agenda, and advice on upgrading its scientific and
research facilities and training opportunities. It will also provide,
where requested, expert review of Agency sponsored intramural and
extramural scientific research programs.
    Date and Time: The meeting will be held on Wednesday, November 19,
2014, from approximately 8:30 a.m. to

5:30 p.m., and Thursday, November 20, 2014, from approximately 8:30
a.m. to 12:45 p.m.
    Location: FDA White Oak Campus, 10903 New Hampshire Ave., Building
31 Conference Center, the Great Room (Rm. 1503), Sections B and C,
Silver Spring, Maryland 20993. For those unable to attend in person,
the meeting will also be Web cast. The link for the Web cast is
available at https://collaboration.fda.gov/scienceboard. Information
regarding special accommodations due to a disability, visitor parking,
and transportation may be accessed at: http://www.fda.gov/AdvisoryCommittees/default.htm; under the heading ``Resources for
You,'' click on ``Public Meetings at the FDA White Oak Campus.'' Please
note that visitors to the White Oak Campus must enter through Building
1.
    Contact Person: Martha Monser, Office of the Chief Scientist,
Office of the Commissioner, Food and Drug Administration, Bldg. 32, Rm.
4286, 10903 New Hampshire Ave., Silver Spring, Maryland 20993, 301-796-
4627<EMAIL_ADDRESS>or FDA Advisory Committee Information
Line, 1-800-741-8138<PHONE_NUMBER> in the Washington, DC area). A
notice in the Federal Register about last minute modifications that
impact a previously announced advisory committee meeting cannot always
be published quickly enough to provide timely notice. Therefore, you
should always check the Agency's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the appropriate
advisory committee meeting link, or call the advisory committee
information line to learn about possible modifications before coming to
the meeting.
    Agenda: On November 19, 2014, the Science Board will review the
existing nonclinical and clinical data related to the use and potential
toxicity of anesthetics and sedation drugs in the pediatric population.
The Science Board will be asked to make recommendations on steps the
FDA should take to further evaluate and to mitigate the risks
associated with the use of these drugs in the pediatric population and
mechanisms to best communicate with the public regarding this issue.
    On November 20, 2014, the Science Board will be provided with
progress reports from two subcommittees, the Commissioner's Fellowship
Program Evaluation subcommittee and the Science Moving Forward
subcommittee. The Board will be asked to support the formation of a new
subcommittee to evaluate the Office of Regulatory Affairs' current
investments in the Food Emergency Response Network cooperative
agreement program and funding for state laboratories to achieve
International Organization for Standardization accreditation. The Board
will also be asked to support the formation of a new subcommittee to
evaluate the Centers of Excellence in Regulatory Science and Innovation
program. A recipient of one of the fiscal year 2013 Scientific
Achievement Awards (selected by the Board) will provide an overview of
the activities for which the award was given.
    FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its Web site prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's Web site after the meeting. Background material is
available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee link.
    Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions pertaining to issues before the Board on November
19, 2014, may be made to the contact person on or before Wednesday,
November 12, 2014. Oral presentations from the public will be scheduled
between approximately 1 p.m. and 2 p.m. on November 19, 2014. Those
individuals interested in making formal oral presentations should
notify the contact person and submit a brief statement of the general
nature of the evidence or arguments they wish to present, the names and
addresses of proposed participants, and an indication of the
approximate time requested to make their presentation on or before
Tuesday, November 4, 2014. Time allotted for each presentation may be
limited. If the number of registrants requesting to speak is greater
than can be reasonably accommodated during the scheduled open public
hearing session, FDA may conduct a lottery to determine the speakers
for the scheduled open public hearing session. The contact person will
notify interested persons regarding their request to speak at the
November 19, 2014, meeting by Wednesday, November 5, 2014.
    Written submissions pertaining to issues before the Board on
November 20, 2014, may be made to the contact person on or before
Thursday, November 13, 2014. Oral presentations from the public will be
scheduled between approximately 12 p.m. and 12:30 p.m. on November 20,
2014. Those individuals interested in making formal oral presentations
should notify the contact person and submit a brief statement of the
general nature of the evidence or arguments they wish to present, the
names and addresses of proposed participants, and an indication of the
approximate time requested to make their presentation on or before
Wednesday, November 5, 2014. Time allotted for each presentation may be
limited. If the number of registrants requesting to speak is greater
than can be reasonably accommodated during the scheduled open public
hearing session, FDA may conduct a lottery to determine the speakers
for the scheduled open public hearing session. The contact person will
notify interested persons regarding their request to speak at the
November 20, 2014, meeting by Thursday, November 6, 2014.
    Persons attending FDA's advisory committee meetings are advised
that the Agency is not responsible for providing access to electrical
outlets.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Martha Monser at
least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: October 2, 2014.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2014-24001 Filed 10-7-14; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register: March 17, 2006 (Volume 71, Number 52)]
[Notices]
[Page 13826-13827]
[DOCID:fr17mr06-58]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP06-78-000]

Southwest Gas Transmission Company; Notice of Application

March 10, 2006.
    Take notice that Southwest Gas Transmission Company, P.O. Box
98510, Las Vegas, Nevada 89193-8510, filed in Docket No. CP06-78-000 on
March 1, 2006, a request pursuant to section 7(c) of the Natural Gas
Act (NGA) and subpart F of part 157 of the Commission's Regulations
under the NGA for a blanket certificate of public convenience and
necessity authorizing Southwest Gas to engage in any of the activities
specified in subpart F of part 157 of the Commission's Regulations, as
may be amended from time to time, all as more fully set forth in the
request which is on file with the Commission and open to public
inspection. The filing may also be viewed on the Web at http://www.ferc.gov
 using the ``eLibrary'' link. Enter the docket number

excluding the last three digits in the docket number field to access
the document. For assistance, contact FERC at
<EMAIL_ADDRESS>or call toll-free,<PHONE_NUMBER> or TYY,

(202) 502-8659.
    Any questions regarding this application should be directed to
Edward C. McMurtrie, Director/Federal Regulatory Affairs, Southwest Gas
Corporation, P.O. Box 98510, Las Vegas, Nevada 89193-8510, at (702)
876-7109 (telephone) or<PHONE_NUMBER> (fax).
    There are two ways to become involved in the Commission's review of
this project. First, any person wishing to obtain legal status by
becoming a party to the proceedings for this project should, on or
before the comment date, file with the Federal Energy Regulatory
Commission, 888 First Street, NE., Washington, DC 20426, a motion to
intervene in accordance with the requirements of the Commission's Rules
of Practice and Procedure (18 CFR 385.214 or 385.211) and the
Regulations under the NGA (18 CFR 157.10). A person obtaining party
status will be placed on the service list maintained by the Secretary
of the Commission and will receive copies of all documents filed by the
applicant and by all other parties. A party must submit 14 copies of
filings made with the Commission and must mail a copy to the applicant
and to every other party in the proceeding. Only parties to the
proceeding can ask for court review of Commission orders in the
proceeding.

    The Commission strongly encourages electronic filings of comments,
protests, and interventions via the Internet in lieu of paper. See 18
CFR 385.2001(a)(1)(iii) and the instructions on the Commission's Web
site (http://www.ferc.gov) under the ``e-Filing'' link.

    Comment Date: March 31, 2006.

Magalie R. Salas,
Secretary.
[FR Doc. E6-3876 Filed 3-16-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 20 (Thursday, January 30, 2014)]
[Notices]
[Page 4948]
[FR Doc No: 2014-01791]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4159-DR; Docket ID FEMA-2014-0003]

Texas; Amendment No. 1 to Notice of a Major Disaster Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster declaration
for the State of Texas (FEMA-4159-DR), dated December 20, 2013, and
related determinations.

DATES: Effective Date: January 17, 2014.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW.,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The notice of a major disaster declaration
for the State of Texas is hereby amended to include the following area
among those areas determined to have been adversely affected by the
event declared a major disaster by the President in his declaration of
December 20, 2013.

    Freestone County for Public Assistance. The following Catalog of
Federal Domestic Assistance Numbers (CFDA) are to be used for
reporting and drawing funds: 97.030, Community Disaster Loans;
97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster
Legal Services; 97.034, Disaster Unemployment Assistance (DUA);
97.046, Fire Management Assistance Grant; 97.048, Disaster Housing
Assistance to Individuals and Households In Presidentially Declared
Disaster Areas; 97.049, Presidentially Declared Disaster
Assistance--Disaster Housing Operations for Individuals and
Households; 97.050 Presidentially Declared Disaster Assistance to
Individuals and Households--Other Needs; 97.036, Disaster Grants--
Public Assistance (Presidentially Declared Disasters); 97.039,
Hazard Mitigation Grant.

W. Craig Fugate,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2014-01791 Filed 1-29-14; 8:45 am]
BILLING CODE 9111-23-P